| 000 | 01548 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518050211.0 | ||
| 264 | 0 | _c20200311 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2019.105688 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhuang, Yuan | |
| 245 | 0 | 0 |
_aApplication of immune repertoire sequencing in cancer immunotherapy. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cSep 2019 |
||
| 300 |
_a105688 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aBiomarkers, Pharmacological |
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 |
_aCostimulatory and Inhibitory T-Cell Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGenes, T-Cell Receptor beta _xgenetics |
| 650 | 0 | 4 | _aHigh-Throughput Nucleotide Sequencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Heavy Chains _xgenetics |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 |
_aReceptors, Antigen, B-Cell _xgenetics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZhang, Changzheng | |
| 700 | 1 | _aWu, Qiong | |
| 700 | 1 | _aZhang, Jing | |
| 700 | 1 | _aYe, Zhenlong | |
| 700 | 1 | _aQian, Qijun | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 74 _gp. 105688 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2019.105688 _zAvailable from publisher's website |
| 999 |
_c29873053 _d29873053 |
||